학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 3건 | 목록
1~20
Conference
Proceedings of 2012 2nd International Conference on Computer Science and Network Technology Computer Science and Network Technology (ICCSNT), 2012 2nd International Conference on. :71-75 Dec, 2012
Academic Journal
Bange, Erin M.; Han, Nicholas A.; Wileyto, Paul; Kim, Justin Y.; Gouma, Sigrid; Robinson, James; Greenplate, Allison R.; Hwee, Madeline A.; Porterfield, Florence; Owoyemi, Olutusin; Naik, Karan; Zheng, Cathy; Galantino, Michael; Weisman, Ariel R.; Ittner, Caroline A.G.; Kugler, Emily M.; Baxter, Amy E.
Nature Medicine. July, 2021, Vol. 27 Issue 7, p1280, 10 p.
Academic Journal
Bange EM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Han NA; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Wileyto P; Abramson Cancer Center, University of Pennsylvania.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania.; Kim JY; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Gouma S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania.; Robinson J; Abramson Cancer Center, University of Pennsylvania.; Greenplate AR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Porterfield F; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Owoyemi O; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Naik K; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Zheng C; Abramson Cancer Center, University of Pennsylvania.; Galantino M; Abramson Cancer Center, University of Pennsylvania.; Weisman AR; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Ittner CAG; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Kugler EM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Baxter AE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Oniyide O; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Agyekum RS; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Dunn TG; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Jones TK; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Giannini HM; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Weirick ME; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania.; McAllister CM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania.; Babady NE; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center.; Kumar A; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Widman AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center.; DeWolf S; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Boutemine SR; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Roberts C; Abramson Cancer Center, University of Pennsylvania.; Budzik KR; Abramson Cancer Center, University of Pennsylvania.; Tollett S; Abramson Cancer Center, University of Pennsylvania.; Wright C; Abramson Cancer Center, University of Pennsylvania.; Perloff T; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Pennsylvania Hospital.; Sun L; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Mathew D; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Giles JR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy.; Oldridge DA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania.; Wu JE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy.; Alanio C; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy.; Adamski S; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Garfall AL; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Vella L; Department of Pediatrics, Perelman School of Medicine, Children's Hospital of Philadelphia.; Kerr SJ; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Lancaster General Hospital.; Cohen JV; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Pennsylvania Hospital.; Oyer RA; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Lancaster General Hospital.; Massa R; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, Presbyterian Hospital.; Maillard IP; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Maxwell KN; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Reilly JP; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Maslak PG; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center.; Vonderheide RH; Abramson Cancer Center, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy.; Wolchok JD; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center.; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Hensley SE; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania.; Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy.; Meyer N; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Division of Pulmonary and Critical Care, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; DeMichele AM; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Vardhana SA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center.; Department of Medicine, Memorial Sloan Kettering Cancer Center.; Parker Institute for Cancer Immunotherapy.; Mamtani R; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Huang AC; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania.; Abramson Cancer Center, University of Pennsylvania.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania.; Parker Institute for Cancer Immunotherapy.
Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Naik, Karan
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어